Robert Schrepfer - SVP - NEW BUS DEV & SPEC SALES, Ani Pharmaceuticals Inc

As of March 29, 2021


Robert Schrepfer Net Worth

  • Net worth is estimated to be at least $5.03M
  • Owns at least 55,927 units of Ani Pharmaceuticals Inc stock
  • Sold an estimated value of $3.29M in the last 8 years at Ani Pharmaceuticals Inc

Robert Schrepfer Trading

  • Largest purchase of shares was 18,750 units , worth over $539.25K on March 5, 2018
  • Largest sale of shares was 28,652 units , worth over $1.77M on March 5, 2018
  • In total has made about 21 transactions over 8 years
  • Usually trades in April, with the busiest year in 2019 and 2018
Ticker
Type
Value
Price per Share
Shares
Filing Date
No matching records found
1

Robert Schrepfer Mailing Address

  • Mailing address is 210 Main Street West C/o Biosante Pharmaceuticals, Inc. Baudette MN 56623 MN

Ani Pharmaceuticals Inc Insider Trading

  • The most recent transaction was 4,000 units bought on March 17, 2021 by Patrick D Walsh worth over $131.56K
  • In the last 8 years, insiders at Ani Pharmaceuticals Inc sold an estimated value of $106.82M and bought an estimated value of $5.08M
  • The most active traders are Arthur Przybyl, President and CEO,  Charlotte C Arnold, Vice President and CFO,  and Robert Schrepfer, SVP - NEW BUS DEV & SPEC SALES
  • Insider trading is most common in April, with the busiest year in 2013

ANI PHARMACEUTICALS INC Insider Trades

Insider Names
Type
Value
Price per Share
Shares
Filing Date
No matching records found
1